OncoDNA

OncoDNA is a commercial-stage diagnostics company specializing in precision oncology. It offers a vertically integrated suite of products including the OncoDEEP® Kit for solid tumor profiling, the OncoSELECT® Kit for liquid biopsy, and the OncoKDM® software for clinical decision support, all designed to simplify NGS testing and interpretation for labs and clinicians. The company serves three core customer segments: clinical laboratories, pharmaceutical companies (for clinical trial enrollment and biomarker discovery), and healthcare institutions. As a subsidiary of IntegraGen, OncoDNA is positioned as a key European player in the growing market for comprehensive genomic profiling in cancer care.

Portfolio of NGS-based genomic profiling kits for solid and liquid tumor biopsies (OncoDEEP®, OncoSELECT®, OncoXPLORE®) integrated with clinical decision support (OncoKDM®) and clinical data intelligence (OncoCDI®) software.

OncoDNA competes in a crowded field with large, established players like Foundation Medicine (Roche), Guardant Health, and Thermo Fisher Scientific, as well as numerous other specialty diagnostic companies. Its differentiation lies in its integrated kit-and-software approach, focus on laboratory partnerships, and its position as a European-based provider with CE-IVD marked products.